<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60352</article-id><article-id pub-id-type="doi">10.7554/eLife.60352</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group></article-categories><title-group><article-title>A statistical framework for assessing pharmacological response and biomarkers using uncertainty estimates</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-194406"><name><surname>Wang</surname><given-names>Dennis</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0068-1005</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195720"><name><surname>Hensman</surname><given-names>James</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-194408"><name><surname>Kutkaite</surname><given-names>Ginte</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-194409"><name><surname>Toh</surname><given-names>Tzen S</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215567"><name><surname>Galhoz</surname><given-names>Ana Claudia Paulo</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160794"><name><surname>Dry</surname><given-names>Jonathan R</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-156760"><name><surname>Saez-Rodriguez</surname><given-names>Julio</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-194411"><name><surname>Garnett</surname><given-names>Mathew J</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-148072"><name><surname>Menden</surname><given-names>Michael P</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-194405"><name><surname>Dondelinger</surname><given-names>Frank</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1816-6300</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="fn" rid="conf4"/></contrib><aff id="aff1"><institution content-type="dept">Sheffield Institute for Translational Neuroscience</institution>, <institution>University of Sheffield</institution>, <addr-line><named-content content-type="city">Sheffield</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution>PROWLER.io</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Computational Biology</institution>, <institution>Helmholtz Zentrum Muenchen</institution>, <addr-line><named-content content-type="city">Munich</named-content></addr-line>, <country>Germany</country></aff><aff id="aff4"><institution content-type="dept">The Medical School</institution>, <institution>University of Sheffield</institution>, <addr-line><named-content content-type="city">Sheffield</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution>AstraZeneca</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution>Heidelberg University</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff7"><institution content-type="dept">Translational Cancer Genomics</institution>, <institution>Wellcome Sanger Institute</institution>, <addr-line><named-content content-type="city">Hinxton</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff8"><institution content-type="dept">Institute of Computational Biology</institution>, <institution>Helmholtz Zentrum München</institution>, <addr-line><named-content content-type="city">Neuherberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff9"><institution>Lancaster University</institution>, <addr-line><named-content content-type="city">Lancaster</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-35863"><name><surname>Lehár</surname><given-names>Joseph</given-names></name><role>Reviewing editor</role><aff><institution>Boston University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>dennis.wang@sheffield.ac.uk</email> (DW);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>michael.menden@helmholtz-muenchen.de</email> (MM);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>fdondelinger.work@gmail.com</email> (FD);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>04</day><month>12</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e60352</elocation-id><history><date date-type="received"><day>24</day><month>06</month><year>2020</year></date><date date-type="accepted"><day>04</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Wang et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Wang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-60352-v2.pdf"/><abstract><p>High-throughput testing of drugs across molecular-characterised cell lines can identify candidate treatments and discover biomarkers. However, the cells' response to a drug is typically quantified by a summary statistic from a best-fit dose-response curve, whilst neglecting the uncertainty of the curve fit and the potential variability in the raw readouts. Here, we model the experimental variance using Gaussian Processes, and subsequently, leverage uncertainty estimates to identify associated biomarkers with a new Bayesian framework. Applied to <italic>in vitro</italic> screening data on 265 compounds across 1,074 cancer cell lines, our models identified 24 clinically established drug response biomarkers, and provided evidence for 6 novel biomarkers by accounting for association with low uncertainty. We validated our uncertainty estimates with an additional drug screen of 26 drugs, 10 cell lines with 8 to 9 replicates. Our method is applicable to any dose-response data without replicates, and improves biomarker discovery for precision medicine.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>NIHR Sheffield Biomedical Research Centre</institution></institution-wrap></funding-source><award-id>BRC - IS-BRC-1215-20017</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Dennis</given-names></name><name><surname>Toh</surname><given-names>Tzen S</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000833</institution-id><institution>Rosetrees Trust</institution></institution-wrap></funding-source><award-id>A2501</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Dennis</given-names></name><name><surname>Toh</surname><given-names>Tzen S</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000691</institution-id><institution>Academy of Medical Sciences</institution></institution-wrap></funding-source><award-id>SBF004/1052</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Dennis</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>206194</award-id><principal-award-recipient><name><surname>Garnett</surname><given-names>Mathew J</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>European Union's Horizon 2020 Research and Innovation Programme</institution></institution-wrap></funding-source><award-id>Grant agreement No. 950293 - COMBAT-RES</award-id><principal-award-recipient><name><surname>Menden</surname><given-names>Michael P</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>James Hensman, James Hensman is an employee of Amazon.com. The author has no competing financial interests to declare..</p></fn><fn fn-type="conflict" id="conf3"><p>Jonathan R Dry, Jonathan Dry is affiliated with AstraZeneca. The author has no competing financial interests to declare..</p></fn><fn fn-type="conflict" id="conf4"><p>Frank Dondelinger, Frank Dondelinger is an employee of Roche. The author has no competing financial interests to declare..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data is available through the GDSC downloads portal (ftp://ftp.sanger.ac.uk/pub4/cancerrxgene/releases)Raw dose response data have been deposited in GDSC under v17a_public_raw_data.csvSigmoid fitted dose-response curves have been deposited in GDSC under v17_fitted_dose_response.csvCell line genomics data have been deposited in GDSC under GDSCtools_mobems.zipCell line identity details have been deposited in GDSC under Cell_Lines_Details.xlsxDrug compound details have been been deposited in GDSC under screened_compunds_rel_8.2.csv</p></sec><supplementary-material><ext-link xlink:href="elife-60352-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>